Evidence map›Paper›PMID 37554546›Full record

ArticleFASEB bioAdvances2023

An insight on the

Büşra Günay, Elizabeth Matthews, Jack Morgan, Marianna A Tryfonidou, Radka Saldova, Abhay Pandit

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in FASEB bioAdvances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Glycosylation in aging and neurodegenerative diseases.Acta biochimica et biophysica Sinica · 2024
    Review
  3. An insight on theFASEB bioAdvances · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Büşra GünayCÚRAM SFI Research Centre for Medical Devices University of Galway Galway Ireland.
Elizabeth MatthewsNIBRT GlycoScience Group National Institute for Bioprocessing Research and Training (NIBRT) Dublin Ireland.
Jack MorganNIBRT GlycoScience Group National Institute for Bioprocessing Research and Training (NIBRT) Dublin Ireland.
Marianna A TryfonidouFaculty of Veterinary Medicine, Department of Clinical Sciences Utrecht University Utrecht The Netherlands.
Radka SaldovaNIBRT GlycoScience Group National Institute for Bioprocessing Research and Training (NIBRT) Dublin Ireland.
Abhay PanditCÚRAM SFI Research Centre for Medical Devices University of Galway Galway Ireland.ORCID https://orcid.org/0000-0002-6292-4933

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Degeneration of the intervertebral disc is an age-related condition. It also accompanies the disappearance of the notochordal cells, which are remnants of the developmental stages of the nucleus pulposus (NP). Molecular changes such as extracellular matrix catabolism, cellular phenotype, and glycosaminoglycan loss in the NP have been extensively studied. However, as one of the most significant co- and posttranslational modifications, glycosylation has been overlooked in cells in degeneration. Here, we aim to characterize the

Indexed as

agingintervertebral disc degenerationliquid chromatography‐mass spectrometryN‐glycosylationnotochordal cellsnucleus pulposus

Identifiers

PMID37554546
PMCPMC10405234

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.